Package 0023-6498-04

{"route": ["ORAL"], "spl_id": "07fd3ef4-ef45-4b86-a6ab-75457fbe68ca", "openfda": {"nui": ["N0000193917", "N0000193918"], "unii": ["AD0O8X2QJR"], "rxcui": ["2268221", "2268227", "2268229", "2268231"], "spl_set_id": ["fd9f9458-fd96-4688-be3f-f77b3d1af6ab"], "pharm_class_epc": ["Calcitonin Gene-related Peptide Receptor Antagonist [EPC]"], "pharm_class_moa": ["Calcitonin Gene-related Peptide Receptor Antagonists [MoA]"], "manufacturer_name": ["Allergan, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "1 PACKET in 1 BOX (0023-6498-01)  / 1 TABLET in 1 PACKET", "package_ndc": "0023-6498-01", "marketing_start_date": "20191223"}, {"sample": true, "description": "4 PACKET in 1 BOX (0023-6498-04)  / 1 TABLET in 1 PACKET", "package_ndc": "0023-6498-04", "marketing_start_date": "20191223"}, {"sample": false, "description": "10 PACKET in 1 BOX (0023-6498-10)  / 1 TABLET in 1 PACKET (0023-6498-02)", "package_ndc": "0023-6498-10", "marketing_start_date": "20191223"}, {"sample": false, "description": "16 PACKET in 1 BOX (0023-6498-16)  / 1 TABLET in 1 PACKET (0023-6498-02)", "package_ndc": "0023-6498-16", "marketing_start_date": "20191223"}, {"sample": false, "description": "30 PACKET in 1 BOX (0023-6498-30)  / 1 TABLET in 1 PACKET (0023-6498-02)", "package_ndc": "0023-6498-30", "marketing_start_date": "20191223"}], "brand_name": "UBRELVY", "product_id": "0023-6498_07fd3ef4-ef45-4b86-a6ab-75457fbe68ca", "dosage_form": "TABLET", "pharm_class": ["Calcitonin Gene-related Peptide Receptor Antagonist [EPC]", "Calcitonin Gene-related Peptide Receptor Antagonists [MoA]"], "product_ndc": "0023-6498", "generic_name": "ubrogepant", "labeler_name": "Allergan, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "UBRELVY", "active_ingredients": [{"name": "UBROGEPANT", "strength": "50 mg/1"}], "application_number": "NDA211765", "marketing_category": "NDA", "marketing_start_date": "20191223", "listing_expiration_date": "20261231"}